Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)

Joseph A. Tangrea, Paul S. Albert, Elaine Lanza, Karen Woodson, Don Corle, Marsha Hasson, Randall Burt, Bette Caan, Electra Páskett, Frank Iber, J. Walter Kikendall, Michael P Lance, Moshe Shike, Joel Weissfeld, Arthur Schatzkin

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective: To prospectively examine the association between non-steroidal anti-inflammatory drugs (NSAIDs) use (including dose and dosage schedule) and the recurrence of colorectal adenomas among individuals who were diagnosed with an adenoma at entry into a clinical trial. Methods: For this analysis, participants who completed the full follow-up (n=1905) for the Polyp Prevention Trial (PPT) were evaluated. Information on current use and dose of NSAIDs and other drugs was obtained at baseline and at each subsequent study visit over the duration of the trial. The study endpoint was the recurrence of colorectal adenomas in the 3 years between the 1-year trial colonoscopy (T1) and the end of the trial colonoscopy (T4). Results: There was a significant reduction in overall adenoma recurrence among NSAIDs users (odds ratio [OR]=0.77; 95% confidence interval [CI]: 0.63-0.95), with the greatest effect seen in advanced polyps (OR=0.51; CI: 0.33 0.79). Among aspirin users, we observed a significant dose response for overall adenoma recurrence, with a 40% reduction in the OR association (OR=0.56; 95% CI: 0.31-0.99) among those taking more than 325 mg per day. Conclusion: This prospective study provides further evidence that NSAIDs may play an important role in the chemoprevention of recurrent colorectal adenomas, even those with advanced features.

Original languageEnglish (US)
Pages (from-to)403-411
Number of pages9
JournalCancer Causes and Control
Volume14
Issue number5
DOIs
StatePublished - Jun 2003
Externally publishedYes

Fingerprint

Adenoma
Anti-Inflammatory Agents
Recurrence
Odds Ratio
Pharmaceutical Preparations
Confidence Intervals
Colonoscopy
Polyps
Chemoprevention
Drug Users
Aspirin
Appointments and Schedules
Clinical Trials
Prospective Studies

Keywords

  • Adenomas
  • Non-steroidal anti-inflammatory drugs
  • Prospective
  • Risk

ASJC Scopus subject areas

  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). / Tangrea, Joseph A.; Albert, Paul S.; Lanza, Elaine; Woodson, Karen; Corle, Don; Hasson, Marsha; Burt, Randall; Caan, Bette; Páskett, Electra; Iber, Frank; Kikendall, J. Walter; Lance, Michael P; Shike, Moshe; Weissfeld, Joel; Schatzkin, Arthur.

In: Cancer Causes and Control, Vol. 14, No. 5, 06.2003, p. 403-411.

Research output: Contribution to journalArticle

Tangrea, JA, Albert, PS, Lanza, E, Woodson, K, Corle, D, Hasson, M, Burt, R, Caan, B, Páskett, E, Iber, F, Kikendall, JW, Lance, MP, Shike, M, Weissfeld, J & Schatzkin, A 2003, 'Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)', Cancer Causes and Control, vol. 14, no. 5, pp. 403-411. https://doi.org/10.1023/A:1024990617158
Tangrea, Joseph A. ; Albert, Paul S. ; Lanza, Elaine ; Woodson, Karen ; Corle, Don ; Hasson, Marsha ; Burt, Randall ; Caan, Bette ; Páskett, Electra ; Iber, Frank ; Kikendall, J. Walter ; Lance, Michael P ; Shike, Moshe ; Weissfeld, Joel ; Schatzkin, Arthur. / Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). In: Cancer Causes and Control. 2003 ; Vol. 14, No. 5. pp. 403-411.
@article{8c888474b8094ae8bd7d2679d70abfc3,
title = "Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)",
abstract = "Objective: To prospectively examine the association between non-steroidal anti-inflammatory drugs (NSAIDs) use (including dose and dosage schedule) and the recurrence of colorectal adenomas among individuals who were diagnosed with an adenoma at entry into a clinical trial. Methods: For this analysis, participants who completed the full follow-up (n=1905) for the Polyp Prevention Trial (PPT) were evaluated. Information on current use and dose of NSAIDs and other drugs was obtained at baseline and at each subsequent study visit over the duration of the trial. The study endpoint was the recurrence of colorectal adenomas in the 3 years between the 1-year trial colonoscopy (T1) and the end of the trial colonoscopy (T4). Results: There was a significant reduction in overall adenoma recurrence among NSAIDs users (odds ratio [OR]=0.77; 95{\%} confidence interval [CI]: 0.63-0.95), with the greatest effect seen in advanced polyps (OR=0.51; CI: 0.33 0.79). Among aspirin users, we observed a significant dose response for overall adenoma recurrence, with a 40{\%} reduction in the OR association (OR=0.56; 95{\%} CI: 0.31-0.99) among those taking more than 325 mg per day. Conclusion: This prospective study provides further evidence that NSAIDs may play an important role in the chemoprevention of recurrent colorectal adenomas, even those with advanced features.",
keywords = "Adenomas, Non-steroidal anti-inflammatory drugs, Prospective, Risk",
author = "Tangrea, {Joseph A.} and Albert, {Paul S.} and Elaine Lanza and Karen Woodson and Don Corle and Marsha Hasson and Randall Burt and Bette Caan and Electra P{\'a}skett and Frank Iber and Kikendall, {J. Walter} and Lance, {Michael P} and Moshe Shike and Joel Weissfeld and Arthur Schatzkin",
year = "2003",
month = "6",
doi = "10.1023/A:1024990617158",
language = "English (US)",
volume = "14",
pages = "403--411",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "5",

}

TY - JOUR

T1 - Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)

AU - Tangrea, Joseph A.

AU - Albert, Paul S.

AU - Lanza, Elaine

AU - Woodson, Karen

AU - Corle, Don

AU - Hasson, Marsha

AU - Burt, Randall

AU - Caan, Bette

AU - Páskett, Electra

AU - Iber, Frank

AU - Kikendall, J. Walter

AU - Lance, Michael P

AU - Shike, Moshe

AU - Weissfeld, Joel

AU - Schatzkin, Arthur

PY - 2003/6

Y1 - 2003/6

N2 - Objective: To prospectively examine the association between non-steroidal anti-inflammatory drugs (NSAIDs) use (including dose and dosage schedule) and the recurrence of colorectal adenomas among individuals who were diagnosed with an adenoma at entry into a clinical trial. Methods: For this analysis, participants who completed the full follow-up (n=1905) for the Polyp Prevention Trial (PPT) were evaluated. Information on current use and dose of NSAIDs and other drugs was obtained at baseline and at each subsequent study visit over the duration of the trial. The study endpoint was the recurrence of colorectal adenomas in the 3 years between the 1-year trial colonoscopy (T1) and the end of the trial colonoscopy (T4). Results: There was a significant reduction in overall adenoma recurrence among NSAIDs users (odds ratio [OR]=0.77; 95% confidence interval [CI]: 0.63-0.95), with the greatest effect seen in advanced polyps (OR=0.51; CI: 0.33 0.79). Among aspirin users, we observed a significant dose response for overall adenoma recurrence, with a 40% reduction in the OR association (OR=0.56; 95% CI: 0.31-0.99) among those taking more than 325 mg per day. Conclusion: This prospective study provides further evidence that NSAIDs may play an important role in the chemoprevention of recurrent colorectal adenomas, even those with advanced features.

AB - Objective: To prospectively examine the association between non-steroidal anti-inflammatory drugs (NSAIDs) use (including dose and dosage schedule) and the recurrence of colorectal adenomas among individuals who were diagnosed with an adenoma at entry into a clinical trial. Methods: For this analysis, participants who completed the full follow-up (n=1905) for the Polyp Prevention Trial (PPT) were evaluated. Information on current use and dose of NSAIDs and other drugs was obtained at baseline and at each subsequent study visit over the duration of the trial. The study endpoint was the recurrence of colorectal adenomas in the 3 years between the 1-year trial colonoscopy (T1) and the end of the trial colonoscopy (T4). Results: There was a significant reduction in overall adenoma recurrence among NSAIDs users (odds ratio [OR]=0.77; 95% confidence interval [CI]: 0.63-0.95), with the greatest effect seen in advanced polyps (OR=0.51; CI: 0.33 0.79). Among aspirin users, we observed a significant dose response for overall adenoma recurrence, with a 40% reduction in the OR association (OR=0.56; 95% CI: 0.31-0.99) among those taking more than 325 mg per day. Conclusion: This prospective study provides further evidence that NSAIDs may play an important role in the chemoprevention of recurrent colorectal adenomas, even those with advanced features.

KW - Adenomas

KW - Non-steroidal anti-inflammatory drugs

KW - Prospective

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=0041488657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041488657&partnerID=8YFLogxK

U2 - 10.1023/A:1024990617158

DO - 10.1023/A:1024990617158

M3 - Article

VL - 14

SP - 403

EP - 411

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 5

ER -